![Olivier de Beaumont](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier de Beaumont
Directeur Technique/Scientifique/R&D chez
Stallergenes Greer, Inc.
Profil
Olivier de Beaumont is currently the Senior VP & Head-Global Clinical Development at Stallergenes Greer, Inc. He previously worked as the Senior Vice President-Global Medical Affairs at Stallergenes SA and as the Chief Medical Officer & Head-Regulatory Affairs at Valerio Therapeutics SA. Dr. de Beaumont holds an MBA degree from ESCP Europe.
Postes actifs de Olivier de Beaumont
| Sociétés | Poste | Début |
|---|---|---|
Stallergenes Greer, Inc.
 Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Anciens postes connus de Olivier de Beaumont
| Sociétés | Poste | Fin |
|---|---|---|
| VALERIO THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/09/2022 |
| STALLERGENES | Corporate Officer/Principal | - |
Formation de Olivier de Beaumont
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
ESCP Europe
 ESCP Europe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Health Technology |
